In the new study, the researchers tested ProStrakan's testosterone gel Tostran against a dummy gel in 220 middle-aged and older men. The men used the gel once a day for a year. The insulin resistance ...

and a deal in which Kyowa Kirin gave ADVANZ the global rights to Tostran (testosterone). Give your business an edge with our leading industry insights. Give your business an edge with our leading ...

ADVANZ PHARMA discusses its partnership with Veeva Systems at the Veeva Commercial Summit 2023. Credit: Veeva Systems “We underwent such digital transformation in the last few years, that we engage ...

ADVANZ PHARMA has signed an agreement to acquire the global rights to Tostran ®, a testosterone gel for treating men with hypogonadism, from Kyowa Kirin. Acquisition will further strengthen ADVANZ ...

UK-based drugmaker Advanz Pharma has bought global rights to the testosterone gel Tostran (testosterone) from Japanese biotech Kyowa Kirin (TYO: 4151). The product is used for treating men with ...

Though Tostran “is not currently out of stock”, a spokesperson for its manufacturer Kyowa Kirin told C+D the product was in low stock in “some areas during March 2022”. “This was driven by constraints ...

or to take testosterone gel Tostran, available on the NHS but off-licence, as it’s only registered for male use. I went for the latter. Increased facial and body hair is a known side effect of ...

1. Young male cancer survivors with low-normal serum morning total testosterone benefited from testosterone treatment as a therapeutic option to improve body composition.

Dublin, May 29, 2017 -- Research and Markets has announced the addition of the "Testosterone Replacement Therapy (TRT) - Global Strategic Business Report" report to their offering. The report ...

NEW YORK, May 29, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The Global and the US markets are further analyzed by ...